| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
---
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
---
|
|
TheStreet.com
---
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.9 | 0.9 |
| Stocks | 89.44 | 89.44 |
| Bonds | 0.0 | 0.0 |
| Other | 2.7 | 2.7 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 6.96 | 6.96 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 01.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 01.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Celldex Therapeutics, Inc. | CLDX | 85.54 | 2.15 |
| Aegerion Pharmaceuticals, Inc. | AEGR | 71.99 | 2.0 |
| DexCom, Inc. | DXCM | 24.36 | 1.92 |
| SodaStream International Ltd. | SODA | 16.91 | 1.9 |
| Sarepta Therapeutics Inc | SRPT | 20.74 | 1.87 |
| Piper Jaffray Cos | PJC | 1.0 | 1.81 |
| Vascular Solutions, Inc. | VASC | -4.43 | 1.79 |
| Performant Financial Corp | PFMT | -2.97 | 1.71 |
| Imperva Inc | IMPV | 21.76 | 1.71 |
| Trex Company, Inc. | TREX | 26.97 | 1.65 |
